Australia markets open in 38 minutes

Optiscan Imaging Limited (OIL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1950-0.0200 (-9.30%)
At close: 04:10PM AEST

Optiscan Imaging Limited

16 Miles Street
Mulgrave, VIC 3170
61 3 9538 3333

IndustryScientific & Technical Instruments
Full-time employees

Key executives

NameTitlePayExercisedYear born
Prof. Camile Farah M.A.I.C.D., M.B.A., Ph.D.CEO & Executive Director568.57kN/AN/A
Mr. Brendan FafianiChief Operating OfficerN/AN/AN/A
Mr. Justin Mouchacca B.Bus (Acc), C.A., CACompany Secretary78kN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, and Internationally. It offers InVivage, an intra-oral digital hand-held confocal endomicroscope for oral cancer screening and/or surgical margin determination; and ViewnVivo, a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery. Optiscan Imaging Limited was founded in 1994 and is headquartered in Mulgrave, Australia.

Corporate governance

Optiscan Imaging Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.